These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16646256)

  • 1. [European Union's strategies on chemicals].
    Binetti R; Attias L; Scimonelli L
    Epidemiol Prev; 2005; 29(5-6 Suppl):22-6. PubMed ID: 16646256
    [No Abstract]   [Full Text] [Related]  

  • 2. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars.
    Gitter DM
    Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759
    [No Abstract]   [Full Text] [Related]  

  • 3. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
    Bjerrum OJ
    Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Union's tobacco products directive.
    McKee M
    BMJ; 2013 Oct; 347():f6196. PubMed ID: 24133144
    [No Abstract]   [Full Text] [Related]  

  • 5. The threats and challenges of REACH.
    European Diagnostic Manufacturers Association
    Med Device Technol; 2005 Dec; 16(10):24-5. PubMed ID: 16419922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the wake of the Mediator scandal: some progress in France, but apathy at the European level.
    Prescrire Int; 2012 Apr; 21(126):110. PubMed ID: 22515143
    [No Abstract]   [Full Text] [Related]  

  • 8. European Union joins fight over drug patents.
    Watson R
    BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440933
    [No Abstract]   [Full Text] [Related]  

  • 9. The dilemmas of the European Union's open access to data policy.
    Destremau B; Giacaman R; Harb M; Herrera L; Mexi M; Mitwalli S; Murphy EC; Rabaia Y; Welchman L; Zambelli E
    Lancet; 2017 Jul; 390(10090):122-123. PubMed ID: 28699585
    [No Abstract]   [Full Text] [Related]  

  • 10. To patent or not to patent: the European Union's new biotech directive.
    Nenow L
    Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115
    [No Abstract]   [Full Text] [Related]  

  • 11. The European Union's Investment and Future Role in Dermatologic Research.
    Leigh IM
    J Invest Dermatol; 2016 Jul; 136(7):1307-1310. PubMed ID: 27342032
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of visual media in the era of European Union's General Data Protection Regulation: A practice-oriented guideline.
    Ponchietti L; Muralha Antunes NF; Utrilla Fornals A; Talving P; Garcea A; Roldón Golet M; García Dominguez M; Yanez Benitez C
    Cir Esp (Engl Ed); 2021; 99(6):404-411. PubMed ID: 34130812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Union's role in public health unsettled.
    Rogers A
    Lancet; 1996 Apr; 347(9008):1107. PubMed ID: 8602068
    [No Abstract]   [Full Text] [Related]  

  • 14. EMEA approves OGS drug rejected by FDA.
    Mitchell P
    Nat Biotechnol; 2002 Sep; 20(9):858-9. PubMed ID: 12205490
    [No Abstract]   [Full Text] [Related]  

  • 15. European Parliament approves pharma law overhaul.
    Rogers A
    Lancet; 2002 Nov; 360(9343):1397-8. PubMed ID: 12423990
    [No Abstract]   [Full Text] [Related]  

  • 16. Shout about the European Union's success.
    Goossens H
    Nature; 2017 Feb; 542(7641):273. PubMed ID: 28202984
    [No Abstract]   [Full Text] [Related]  

  • 17. European Commission targets drug firms over illegal patent protection.
    Watson R
    BMJ; 2010 Jan; 340():c268. PubMed ID: 20080819
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharma industry under antitrust security.
    Addy G; Banicevic A; Katz M; Rosen H
    Health Law Can; 2010 Feb; 30(3):146-8. PubMed ID: 20422811
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients' right to quality of healthcare: how satisfactory are the European Union's regulatory policies?
    Abbing HR
    Eur J Health Law; 2012 Dec; 19(5):415-22. PubMed ID: 23198483
    [No Abstract]   [Full Text] [Related]  

  • 20. European Commission wants drug companies to test products for use in children.
    Watson R
    BMJ; 2004 Oct; 329(7470):818. PubMed ID: 15472249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.